Canaccord Genuity Upgrades Biogen (BIIB) to Buy

February 27, 2013 7:38 AM EST Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $307.69 +0.91%

Rating Summary:
    21 Buy, 8 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade BIIB Now!
Join SI Premium – FREE
Canaccord Genuity upgraded Biogen (NASDAQ: BIIB) from Hold to Buy with a price target of $187.00 (from $163.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $161.99 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Canaccord Genuity

Add Your Comment